These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21786368)

  • 1. Immunity against a therapeutic xenoprotein/Fc construct delivered by gene transfer is reduced through binding to the inhibitory receptor FcγRIIb.
    Liang Y; Qiu H; Glinka Y; Lazarus AH; Ni H; Prud'homme GJ; Wang Q
    J Gene Med; 2011 Sep; 13(9):470-7. PubMed ID: 21786368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes.
    Soltani N; Kumar M; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jun; 14(12):981-8. PubMed ID: 17410180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
    Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular gene transfer of soluble B7.1/IgG(1) fusion cDNA induces potent antitumor immunity as an adjuvant for DNA vaccination.
    Zhou ZF; Peretz Y; Chang Y; Miao DS; Li X; Prud'homme GJ
    Cancer Gene Ther; 2003 Jun; 10(6):491-9. PubMed ID: 12768195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.
    Zheng XX; Steele AW; Hancock WW; Kawamoto K; Li XC; Nickerson PW; Li Y; Tian Y; Strom TB
    J Immunol; 1999 Oct; 163(7):4041-8. PubMed ID: 10491008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis.
    Adachi O; Nakano A; Sato O; Kawamoto S; Tahara H; Toyoda N; Yamato E; Matsumori A; Tabayashi K; Miyazaki J
    Gene Ther; 2002 May; 9(9):577-83. PubMed ID: 11973633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anorexic effect of Ex4/Fc through GLP-1 receptor activation in high-fat diet fed mice.
    Liu R; Ma D; Li Y; Hu R; Peng Y; Wang Q
    Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):675-81. PubMed ID: 24951724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor.
    Kim JK; Tsen MF; Ghetie V; Ward ES
    Eur J Immunol; 1994 Oct; 24(10):2429-34. PubMed ID: 7925571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment.
    el-Amine M; Hinshaw JA; Scott DW
    Int Immunol; 2002 Jul; 14(7):761-6. PubMed ID: 12096035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular injection of naked plasmid DNA encoding human preproinsulin gene in streptozotocin-diabetes mice results in a significant reduction of blood glucose level.
    Wang LY; Sun W; Chen MZ; Wang X
    Sheng Li Xue Bao; 2003 Dec; 55(6):641-7. PubMed ID: 14695479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
    Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
    Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
    Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
    Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
    Kim JM; Ho SH; Hahn W; Jeong JG; Park EJ; Lee HJ; Yu SS; Lee CS; Lee YW; Kim S
    Gene Ther; 2003 Aug; 10(15):1216-24. PubMed ID: 12858186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice.
    Kim D; Cho SW; Her SJ; Yang JY; Kim SW; Kim SY; Shin CS
    Stem Cells; 2006 Jul; 24(7):1798-805. PubMed ID: 16556708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
    J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor.
    Georgescu MT; Moorehead PC; Liu T; Dumont J; Scott DW; Hough C; Lillicrap D
    Front Immunol; 2020; 11():138. PubMed ID: 32117285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
    Chang Y; Prud'homme GJ
    J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.